CombiMatrix Launches New Prostate Cancer Array-Based Diagnostic Test
CombiMatrix Corporation has announced the introduction of the ProScan, which complements the company’s growing portfolio of array-based diagnostic tests.
Read MoreCombiMatrix Corporation has announced the introduction of the ProScan, which complements the company’s growing portfolio of array-based diagnostic tests.
Read MoreDiazyme Laboratories has announced that the FDA has granted Diazyme 510(k) clearance to market its liquid stable enzymatic lithium test kit for the quantitative determination of lithium levels in blood samples.
Read MoreAgendia has announced MammaPrint’s ability to predict response to neoadjuvant chemotherapy in breast cancer.
Read MorePresident-elect Barack Obama has chosen former Senate Majority Leader Tom Daschle to lead his effort to design an overhaul of the nation’s health care system and shepherd it through Congress.
Read MoreNational Jewish Health and Laboratory Corp of America Holdings have reached an agreement to collaborate in the development and commercialization of molecular diagnostic tests in support of personalized medicine.
Read More